Showing results (361-370 of 385) with videos related to

Sort By:
Pageof 39
Cell Genomics|August 21, 2023
Fancm has dual roles in the limiting of meiotic crossovers and germ cell maintenance in mammalsVanessa Tsui, Ruqian Lyu, Stevan Novakovic, et al.
Future Oncology (London, England)|October 6, 2025
EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial)Maeve A Hennessy, Constantine Gatsonis, Heather Jacene, et al.
Nature Cancer|August 25, 2022
Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in miceAmy L Winship, Lauren R Alesi, Sneha Sant, et al.
Molecular Neurodegeneration|July 16, 2021
Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microgliaDiana P Benitez, Shenyi Jiang, Jack Wood, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 10, 2019
Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelinesJoanne M Bowen, Rachel J Gibson, Janet K Coller, et al.
Future Oncology (London, England)|June 27, 2025
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancerLior Z Braunstein, Melissa P Mitchell, Hanna Bandos, et al.
NEJM Evidence|March 6, 2023
AI Estimation of Gestational Age from Blind Ultrasound Sweeps in Low-Resource SettingsTeeranan Pokaprakarn, Juan C Prieto, Joan T Price, et al.
JAMA|August 1, 2024
Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound SweepsJeffrey S A Stringer, Teeranan Pokaprakarn, Juan C Prieto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast CancerBryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Nature Cancer|March 19, 2026
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study resultsRashmi K Murthy, Barbara J O'Brien, Donald A Berry, et al.
Pageof 39